Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S Common Stock
(NY:
NVO
)
37.65
+0.74 (+2.00%)
Streaming Delayed Price
Updated: 11:28 AM EDT, Apr 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,339,304
Open
38.03
Bid (Size)
37.64 (1,500)
Ask (Size)
37.65 (600)
Prev. Close
36.91
Today's Range
37.54 - 38.19
52wk Range
35.12 - 81.44
Shares Outstanding
N/A
Dividend Yield
3.10%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Absurdly Cheap Dividend Stocks to Buy in April 2026
↗
Today 10:20 EDT
These stocks offer high yields and trade at incredibly low earnings multiples.
Via
The Motley Fool
Topics
Economy
Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine
April 06, 2026
In a move that has sent shockwaves through both the pharmaceutical and technology sectors, Eli Lilly and Company (NYSE: LLY) announced today, April 6, 2026, the finalized acquisition of Contessa, a...
Via
MarketMinute
Topics
Artificial Intelligence
Performance
YTD
-28.1%
-28.1%
1 Month
-5.4%
-5.4%
3 Month
-33.1%
-33.1%
6 Month
-36.2%
-36.2%
1 Year
-40.8%
-40.8%
More News
Read More
Goldman Sachs Forecasts 12% S&P 500 Surge in 2026: The Five Pillars of a Maturing Bull Market
April 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Initial Public Offering
The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports
April 06, 2026
Via
MarketMinute
Topics
Economy
World Trade
Nuclear, Pharma & Travel Buybacks: Confident or Cautious Signals?
↗
April 06, 2026
Via
MarketBeat
Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight
↗
April 04, 2026
Via
The Motley Fool
Earnings Revision Momentum: Why Analysts Upgraded S&P 500 Growth to 17%
April 03, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Why Novo Nordisk's Pricing Shift Could Unlock a Much Larger Obesity Market
↗
April 03, 2026
Via
The Motley Fool
The Great Metabolic Land Grab: Why Viking and Structure Have Become Big Pharma’s 'Irresistible' Targets
April 03, 2026
Via
MarketMinute
Topics
Intellectual Property
Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring
April 02, 2026
Via
MarketMinute
Topics
Economy
The Evolution of The Cigna Group: A Deep Dive into a Health Services Powerhouse (2026)
April 02, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Lawsuit
The Trillion-Dollar Treatment: A Deep Dive into Eli Lilly and Company (LLY)
April 02, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
Why Eli Lilly Stock Trounced the Market Today
↗
April 01, 2026
Via
The Motley Fool
Eli Lilly’s $47.8 Billion Masterstroke: The Contessa Acquisition and the New Era of Pharmaceutical Dominance
April 01, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Could This New Approval Be a Turning Point For Novo Nordisk?
↗
April 01, 2026
Via
The Motley Fool
Is This Weight Loss Drug Stock a Buy After a New Approval?
↗
March 31, 2026
Via
The Motley Fool
The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience
March 31, 2026
Via
Finterra
Topics
Economy
Intellectual Property
1 Reason This Biotech Stock Could Triple Before Year-End
↗
March 29, 2026
Via
The Motley Fool
1 Reason Eli Lilly Stock Is Still a Buy
↗
March 28, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Novo Nordisk: A Strong Contender in the Pharmaceutical Arena
↗
March 27, 2026
Via
The Motley Fool
Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly
March 27, 2026
Via
MarketMinute
Eli Lilly vs Novo Nordisk: Which Obesity Drug Stock Is the Better Buy?
↗
March 27, 2026
Via
The Motley Fool
Could Buying Eli Lilly Today Set You Up for Life?
↗
March 26, 2026
Via
The Motley Fool
Topics
Intellectual Property
What's Happening With Novo Nordisk Stock Today?
↗
March 26, 2026
Via
Benzinga
Wave Life Sciences Shakes Biotech Sector with Breakthrough Obesity Data: A New Era for ‘Quality’ Weight Loss
March 26, 2026
Via
MarketMinute
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 37.65
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 04/08/26 11:28 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.